ANI Pharmaceuticals, Inc. (ANIP): Price and Financial Metrics
ANIP Price/Volume Stats
| Current price | $64.58 | 52-week high | $70.81 |
| Prev. close | $65.48 | 52-week low | $36.99 |
| Day low | $64.43 | Volume | 184,100 |
| Day high | $65.97 | Avg. volume | 138,753 |
| 50-day MA | $64.43 | Dividend yield | N/A |
| 200-day MA | $58.35 | Market Cap | 1.36B |
ANIP Stock Price Chart Interactive Chart >
ANI Pharmaceuticals, Inc. (ANIP) Company Bio
ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The company was founded in 2004 and is based in Baudette, Minnesota.
Latest ANIP News From Around the Web
Below are the latest news stories about ANI PHARMACEUTICALS INC that investors may wish to consider to help them evaluate ANIP as an investment opportunity.
Investing in ANI Pharmaceuticals (NASDAQ:ANIP) three years ago would have delivered you a 59% gainANI Pharmaceuticals, Inc. ( NASDAQ:ANIP ) shareholders have seen the share price descend 23% over the month. But that... |
ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare ConferenceBAUDETTE, Minn., Nov. 22, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President & CEO, will participate at the Piper Sandler 35th Annual Healthcare Conference in New York City as follows: Date: Tuesday, November 28, 2023 Time:1:00pm – 1:25pm ET Webcast: Click Here To schedule a 1x1 meeting with the Company, please contact [email protected]. The live and archived webcast will be accessible from the Company’s web |
A Boring Biopharma Can Be a Good BetInvestors have finally seen some long awaited and much needed breadth within the market rally in recent trading sessions. This strategy provides downside protection of approximately 14% during the five-month option duration. |
Insider Sell Alert: SVP, CHIEF HR OFFICER Krista Davis Sells Shares of ANI Pharmaceuticals IncANI Pharmaceuticals Inc (NASDAQ:ANIP) has recently witnessed an insider sell that has caught the attention of investors and market analysts. |
Is ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock Price Struggling As A Result Of Its Mixed Financials?With its stock down 20% over the past week, it is easy to disregard ANI Pharmaceuticals (NASDAQ:ANIP). It is possible... |
ANIP Price Returns
| 1-mo | -5.25% |
| 3-mo | 16.55% |
| 6-mo | 12.43% |
| 1-year | 63.08% |
| 3-year | 95.64% |
| 5-year | -6.24% |
| YTD | 17.12% |
| 2023 | 37.06% |
| 2022 | -12.70% |
| 2021 | 58.68% |
| 2020 | -52.91% |
| 2019 | 36.98% |
Continue Researching ANIP
Want to do more research on Ani Pharmaceuticals Inc's stock and its price? Try the links below:Ani Pharmaceuticals Inc (ANIP) Stock Price | Nasdaq
Ani Pharmaceuticals Inc (ANIP) Stock Quote, History and News - Yahoo Finance
Ani Pharmaceuticals Inc (ANIP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...